Kim R. Tsuchimoto
Director · Monopar Therapeutics
IndividualSelling only16 10b5-1 trades
- 2025
- Aug 29, 2026
- 3
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kim R. Tsuchimoto files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Chandler Robinson - $2.56M in MNPR purchases and sales in the last 12 months
- Raymond Anderson - $703K in MNPR purchases and sales in the last 12 months
- Christopher M. Starr - $659K in MNPR purchases and sales in the last 12 months
- Patrice Rioux - $111 in MNPR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kim R. Tsuchimoto?
Kim R. Tsuchimoto is a corporate insider, tracked as Director of Monopar Therapeutics (MNPR). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Kim R. Tsuchimoto submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Kim R. Tsuchimoto been buying or selling stock?
Recorded transactions: 0 open-market purchases and 13 open-market sales ($1.27M) across all tracked filings.
